Other Transaction Agreement 70RSAT21T00000011
Award Date
6/17/21
Potential Completion Date
6/16/25
Potential Value
$1.9M
Funding Federal Agency
Science and Technology Directorate
Contracting Federal Agency
Office of Procurement Operations
Awardee
Ministry Of Defence
Ultimate Awardee
Not listed
NAICS Category
Not listed
PSC Category
AJ12 - General Science And Technology R&D Services; General Science And Technology; Applied Research
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed
Major Defense Program
Not listed
Pricing Type
Other
Place of Performance
Great Britain, United Kingdom
Solicitation Procedures
Program Solicitation
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to the Ministry of Defence (MOD), doing business as the Defence Science and Technology Laboratory (DSTL), a United Kingdom government entity. The $4,636,158.00 cost-plus-fixed-fee contract was awarded by the Defense Threat Reduction Agency (DTRA) with a period of performance ending on September 30, 2022. The contract has no set-aside designation. DSTL is an experienced provider of advanced research and development services to U.S. federal agencies, with a focus...
This federal contract award, valued at $5,379,526.00, was issued by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence (MOD), doing business as the Defence Science and Technology Laboratory (DSTL), a United Kingdom government entity. The award is for a base period and does not have a set-aside designation. DSTL has an Indefinite Delivery Vehicle (IDV) contract with the National Institute of Allergy and Infectious Diseases (NIAID) worth up to $146.3 million over seven years,...
The U.S. Defense Threat Reduction Agency awarded a $1,573,426.25 cost-plus-fixed-fee contract to the Ministry of Defence, doing business as DSTL, a UK government entity. The contract is for the "Biological Agent Diagnostic Lexicon for Clinical Information Exploitation", with a completion date of December 15, 2022. This contract supports research and development efforts by U.S. defense and homeland security agencies to counter emerging biological and chemical threats, including...
This is a $1,189,718.74 cost-plus-fixed-fee definitive contract awarded by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence, doing business as D S T L (Defence Science and Technology Laboratory), a United Kingdom government entity. The contract is for research and development of pharmacological and biologic interventions to reduce inflammation and seizures caused by viral encephalitis. This award is not associated with a set-aside program. The original solicitation was a...
The Defense Threat Reduction Agency awarded a $4,387,571.00 Cost Plus Fixed Fee contract to the Ministry of Defence, doing business as D S T L, a U.K. government entity located in Great Britain. The contract is for the development of chemical and biological decision support tools, with a completion date of July 21, 2022. The work supports U.S. defense and homeland security efforts to counter emerging biological and chemical threats, and may involve activities such as research on medical...
This is a cost-plus-fixed-fee delivery order contract awarded by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence, doing business as the Defence Science and Technology Laboratory (DSTL), a United Kingdom government entity. The contract, valued at $4,226,739.50, supports the "BASE PERIOD - AD92" requirement and has an ultimate completion date of June 26, 2021. The contract is not designated as a set-aside. The award is part of a larger Indefinite Delivery Contract...
This is a cost-plus-fixed-fee delivery order contract awarded by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence (MOD) of the United Kingdom, operating as the Defence Science and Technology Laboratory (DSTL). The $1,104,374.25 contract is for diagnostic meta-analysis research, with a period of performance ending on September 30, 2021. As a foreign government entity, DSTL has a proven track record of securing contracts from U.S. federal agencies, including DTRA and the...
This is a $6,400,448.87 cost-plus-fixed-fee definitive contract awarded by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence of the United Kingdom, doing business as the Defence Science and Technology Laboratory (D S T L). The contract is for the development of non-ionic surfactant vesicles (NISVs) as a drug delivery and targeting system for antimicrobials. This contract was awarded under a Broad Agency Announcement (BAA) that solicited proposals for innovative research and...
The Defense Threat Reduction Agency (DTRA) awarded a $1.1 million cost-plus-fixed-fee delivery order contract to the Ministry of Defence, doing business as DSTL, for work under its AD92 program. To be performed in Great Britain from December 2015 through March 2018, this contract calls for DSTL to provide unspecified services to DTRA in support of the agency's counter-weapons-of-mass-destruction efforts. As the prime contractor, DSTL will leverage its expertise conducting scientific research and...
This is a $7,994,572.00 cost-plus-fixed-fee definitive contract awarded by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence (MOD), doing business as the Defence Science and Technology Laboratory (DSTL), a United Kingdom government entity. The contract is for the generation of a novel antibody-antibiotic conjugate as a combination therapy platform to treat melioidosis or plague. This contract is not set aside. DSTL has secured multiple high-value federal contracts from DTRA...